NO20043046L - Peptidrensing - Google Patents

Peptidrensing

Info

Publication number
NO20043046L
NO20043046L NO20043046A NO20043046A NO20043046L NO 20043046 L NO20043046 L NO 20043046L NO 20043046 A NO20043046 A NO 20043046A NO 20043046 A NO20043046 A NO 20043046A NO 20043046 L NO20043046 L NO 20043046L
Authority
NO
Norway
Prior art keywords
sub
solvent
water
mixture
decapeptide
Prior art date
Application number
NO20043046A
Other languages
English (en)
Other versions
NO329024B1 (no
Inventor
Jon H Rasmussen
Palle H Rasmussen
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Publication of NO20043046L publication Critical patent/NO20043046L/no
Publication of NO329024B1 publication Critical patent/NO329024B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20043046A 2001-12-29 2004-07-16 Peptidrensing NO329024B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)
PCT/IB2002/005581 WO2003055900A1 (en) 2001-12-29 2002-12-23 Peptide purification

Publications (2)

Publication Number Publication Date
NO20043046L true NO20043046L (no) 2004-08-30
NO329024B1 NO329024B1 (no) 2010-08-02

Family

ID=20286556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043046A NO329024B1 (no) 2001-12-29 2004-07-16 Peptidrensing

Country Status (18)

Country Link
US (1) US7057014B2 (no)
EP (1) EP1468009B1 (no)
JP (1) JP4378173B2 (no)
KR (1) KR100880828B1 (no)
CN (1) CN1272341C (no)
AT (1) ATE449784T1 (no)
AU (1) AU2002347550B2 (no)
CA (1) CA2471717C (no)
DE (1) DE60234535D1 (no)
DK (1) DK1468009T3 (no)
ES (1) ES2350880T3 (no)
IL (2) IL162789A0 (no)
NO (1) NO329024B1 (no)
NZ (1) NZ534151A (no)
RU (1) RU2303040C2 (no)
SE (1) SE0104462D0 (no)
WO (1) WO2003055900A1 (no)
ZA (1) ZA200405135B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359722A1 (en) * 2002-03-27 2003-11-05 BRITISH TELECOMMUNICATIONS public limited company Data streaming system and method
EP1845973B1 (en) 2005-01-21 2015-08-12 Astex Therapeutics Limited Pharmaceutical compounds
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
CN102027005A (zh) * 2008-05-15 2011-04-20 诺沃-诺迪斯克有限公司 通过固相合成制备的肽的纯化
CN102482326A (zh) * 2009-04-10 2012-05-30 科登制药科罗拉多公司 分离治疗用肽的方法
AU2013360335B2 (en) 2012-12-13 2017-12-07 Immunomedics, Inc. Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
ES2819573T3 (es) 2012-12-13 2021-04-16 Immunomedics Inc Método para producir inmunoconjugados de anticuerpo-SN-38 con un enlazador CL2A
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
EP3024460B1 (en) * 2013-07-23 2020-07-22 Immunomedics, Inc. Method for producing antibody-sn-38 immunoconjugates with a cl2a linker
WO2017189279A1 (en) 2016-04-27 2017-11-02 Immunomedics, Inc. Efficacy of anti-trop-2-sn-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
EP3600283A4 (en) 2017-03-27 2020-12-16 Immunomedics, Inc. TREATMENT OF TROP-2 EXPRESSIVE TRIPLE NEGATIVE BREAST CANCER WITH SACITUZUMAB GOVITECAN AND A RAD51 INHIBITOR
US10799597B2 (en) 2017-04-03 2020-10-13 Immunomedics, Inc. Subcutaneous administration of antibody-drug conjugates for cancer therapy
CN113952944B (zh) * 2021-12-23 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种纯化九肽-1的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317697D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Dissolution of peptides in non-aqueous and mixed non-aqueous/aqueous solvents
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden
EP0998940A1 (en) * 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
DE60234535D1 (de) 2010-01-07
IL162789A0 (en) 2005-11-20
ATE449784T1 (de) 2009-12-15
JP4378173B2 (ja) 2009-12-02
US20060014694A1 (en) 2006-01-19
RU2303040C2 (ru) 2007-07-20
JP2005515217A (ja) 2005-05-26
CA2471717A1 (en) 2003-07-10
DK1468009T3 (da) 2010-04-06
RU2004119965A (ru) 2006-01-10
CN1625561A (zh) 2005-06-08
AU2002347550A1 (en) 2003-07-15
EP1468009A1 (en) 2004-10-20
SE0104462D0 (sv) 2001-12-29
CA2471717C (en) 2013-06-18
CN1272341C (zh) 2006-08-30
ES2350880T3 (es) 2011-01-27
EP1468009B1 (en) 2009-11-25
AU2002347550B2 (en) 2008-01-03
IL162789A (en) 2010-04-29
ZA200405135B (en) 2005-08-31
HK1076112A1 (en) 2006-01-06
KR100880828B1 (ko) 2009-01-30
US7057014B2 (en) 2006-06-06
WO2003055900A1 (en) 2003-07-10
KR20040090966A (ko) 2004-10-27
NO329024B1 (no) 2010-08-02
NZ534151A (en) 2007-05-31

Similar Documents

Publication Publication Date Title
NO20043046L (no) Peptidrensing
MY142836A (en) Self-extinguishing catalyst composition with monocarboxylic acid ester internal donor and propylene polymerization process
ATE181353T1 (de) Treibstoffgemische
DE69925459D1 (de) Verfahren zur herstellung von hochreinen hmg-coa reductase inhibitoren
SI1515962T1 (sl) Postopek za pripravo dioksan estrov ocetne kisline
EP1568740A3 (en) Thickening systems and aqueous-coating compositions, and methods of making and using the same
CA2410451A1 (en) Clarification method for oil dispersions comprising overbased detergents containing calcite
DK0925065T3 (da) Vandblandbare erythromycinsammensætninger
AU552050B2 (en) N-substituted azeheterocyclic carboxylic acids and their esters
ATE258911T1 (de) Verfahren zur herstellung von alkoxyzimtsäureester
AU5421299A (en) Substituted cinnamic acids and cinnamic acid esters
IL174002A0 (en) Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative
WO2004069969A3 (de) Ester konjugiert ungesättigter carbonsäuren (konjugensäurester) verfahren zu ihrer herstellung und ihre verwendung
DE2534515A1 (de) Neue zwischenprodukte zur synthese von beta-lactamderivaten und verfahren zu deren herstellung
GB9914382D0 (en) New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
KR960041184A (ko) 7-[(2-카르보알콕시-1-메틸에테닐)아미노]-3-히드록시메틸-3-세펨-4-카르복시산의 제조방법 및 이의 중간체
RU2000114008A (ru) Способ выделения кислот из углеводородных смесей
KR970027042A (ko) 2-(4-브로모메틸페닐)프로피온산의 제조방법
NO20013528D0 (no) Fremgangsmåte for reduksjon av 3-dimetylamino-2- fenylpropionsyre-etylester-innhold i lösninger av 2-dimetylamino-1-fenyl-3-cykloheksen-1-karboksylsyre-etylester
NO920158D0 (no) Fremgangsmaate for oekning av forholdet for alfa til beta ien aspartam-koblingsreaksjon
WO2002032849A3 (en) Ester compounds and their use in forming acrylates
KR880001631A (ko) 퀴놀린 유도체의 제조 방법
TH63268A (th) การนำอะคริลิก แอซิดกลับคืนมา โดยใช้ เอธิล อะคริเลต และตัวทำละลายร่วม ที่เลือกมา
JPS53147063A (en) Preparation of alpha-acyloxythienyl acetic acids

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees